Resources
Full-Service CRO Overview
We are pleased to share Dr. Vince Clinical Research’s latest brochure, providing an in-depth overview of our full-service CRO solutions.
Human Abuse Potential: Study Management
At Dr. Vince Clinical Research, we conduct Human Abuse Potential (HAP) studies at our state-of-the-art research facility. At ...
Pharmacy Considerations for Early Phase Trials
From sterile compounding to handling controlled substances, a crucial aspect of conducting successful early phase trials is ...
Participant Selection and Recruitment in Human Abuse Potential Clinical Studies
When it comes to clinical studies, particularly those examining human abuse potential (HAP), the way participants are ...
Human Abuse Potential: Participant Recruitment
Here at Dr. Vince Clinical Research, we have built an ideal clinical research facility for human abuse potential (HAP) that ...
Assessing the Abuse Liability of Tobacco and Nicotine Products
Download our white paper to learn more about the assessment of abuse liability in tobacco and nicotine products. Discover ...
Acute Pain Models in Drug Development
Human pain models have been established as effective, cost-efficient tools for evaluating the efficacy of analgesic drugs. ...
10 Lessons Learned Over 40 Years of Drug Development Research in Psychiatry
Sheldon Preskorn, MD, Senior Vice President of Neuroscience, presented “10 Lessons Learned Over 40 Years of Drug Development ...
Effective Study Design and Execution of Renal and Hepatic Impairment Trials
As most medications are primarily excreted through the kidneys or liver, most drugs in development will require a renal ...
How Including Cognition as a Safety Endpoint Provides a Competitive Differentiator
In today’s rapidly evolving pharmaceutical landscape, cognitive safety is emerging as a critical factor that can set ...
From Chance Discovery to Molecular Biology
Dr. Sheldon H. Preskorn's presentation, "From Chance Discovery to Molecular Biology," highlights the evolution of ...
Innovation in a First-In-Human Trial
With over 70,000 annual deaths, fentanyl overdose is the leading cause of death for Americans aged 18-45. In collaboration ...